Health Condition 1: K859- Acute pancreatitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of acute pancreatitis diagnosed as per revised Atlanta classification with two out of the following three points 1. abdominal pain consistent with acute pancreatitis 2. Serum lipase or amylase activity at least three times greater than upper limit of normal 3. Characteristics imaging finding on trans abdominal ultrasound or contrast enhanced computed tomography of abdomen or magnetic resonance imaging of pancreas. The patient diagnosed as acute pancreatitis should be 1.present with in 7 day of pain onset 2.presents with pain abdomen with visual analogue score 3 or more and 3. normal sensorium as defined by Glasgow coma score 15.
Exclusion criteria
Exclusion criteria: Age less than 18 and more than 75. Patient with evidence of chronic pancreatitis. Patient with shock requiring vasopressor. Patient with respiratory failure requiring mechanical ventilation. Patient with serum creatinine more than equal to 1.5 mg per dl. Patient with coronary artery disease. Patient with altered sensorium with Glasgow coma scale less than 15. Patient refuses to give consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure the difference in efficacy of tramadol and diclofenac in pain relief in patients of acute pancreatitis.Timepoint: 40 hours and 3 days of follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| To measure the difference in the adverse events between the diclofenac and tramadol group. Timepoint: 3 days of follow up | — |
Countries
India
Contacts
IPGMER AND SSKM